Medicare Enrolled
Dr. Mark Perlmutter, M.D.
Urology Physician · Manasquan, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Perlmutter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perlmutter?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Perlmutter
Dr. Mark Perlmutter is an urology physician in Manasquan, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Perlmutter performed 5,445 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Perlmutter received a total of $4,874 from 53 pharmaceutical and/or device companies across 284 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Perlmutter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 28% volume in NJ
$4,874 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,445
Medicare services
Top 28% in NJ for urology physician
Not available
Unique patients (not deduplicated)
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,046 | $101 | $710 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
901 | $2 | $16 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
603 | $69 | $501 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
564 | $66 | $382 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
420 | $34 | $116 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
287 | $108 | $723 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 206 | $136 | $710 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
169 | $9 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
109 | $130 | $915 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
101 | $10 | $78 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
97 | $34 | $116 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
96 | $69 | $233 |
| Complicated insertion of bladder tube | 75 | $105 | $838 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
70 | $28 | $186 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
46 | $104 | $1,409 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
45 | $27 | $799 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
39 | $20 | $421 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
35 | $8 | $15 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
34 | $34 | $116 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
34 | $34 | $116 |
| Herpes virus-6 nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of herpes virus-6. |
34 | $34 | $116 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
34 | $34 | $116 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
34 | $148 | $988 |
| CMV nucleic acid detection test A laboratory test that uses amplified probe techniques to detect cytomegalovirus (CMV) genetic material in a sample. |
33 | $34 | $116 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
33 | $34 | $116 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
33 | $34 | $116 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
33 | $34 | $116 |
| Molecular pathology test interpretation A physician reviews and interprets the results of a molecular pathology test to provide a diagnostic report. |
33 | $38 | $102 |
| PSA test (prostate cancer screening) | 32 | $14 | $15 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
31 | $467 | $4,154 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
28 | $66 | $1,343 |
| Imaging guidance for procedure, 60 minutes or less Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less. |
20 | $13 | $242 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
19 | $95 | $2,271 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
17 | $119 | $1,768 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
16 | $110 | $2,545 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
14 | $109 | $4,498 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
12 | $84 | $1,760 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
12 | $341 | $2,223 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.0% high complexity
7.5% medium
91.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,874
Total received (2018-2024)
Avg $696/year across 7 years
Top 26% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
284
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$972
2023
$901
2022
$804
2021
$683
2020
$326
2019
$686
2018
$502
Payments by company (2024)
Edap Technomed Inc
$258
Dendreon Pharmaceuticals LLC
$137
Janssen Biotech, Inc.
$108
Tolmar, Inc.
$81
Telix Pharmaceuticals
$53
ABBVIE INC.
$45
Merck Sharp & Dohme LLC
$35
Myriad Genetic Laboratories, Inc.
$33
Sumitomo Pharma America, Inc.
$32
UROGEN PHARMA, INC.
$32
Agiliti Surgical, Inc.
$26
DENTSPLY IH AB
$23
Ferring Pharmaceuticals Inc.
$18
IMMUNITYBIO, INC.
$17
Novartis Pharmaceuticals Corporation
$16
C. R. Bard, Inc. & Subsidiaries
$16
Astellas Pharma US Inc
$15
PFIZER INC.
$14
PROGENICS PHARMACEUTICALS, INC.
$14
Top 3 companies account for 51.7% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$574
Janssen Biotech, Inc.
$362
PFIZER INC.
$360
Astellas Pharma US Inc
$330
Myriad Genetic Laboratories, Inc.
$272
Edap Technomed Inc
$258
ABBVIE INC.
$197
Myovant Sciences Inc.
$177
Medtronic USA, Inc.
$148
Tolmar, Inc.
$145
Bayer HealthCare Pharmaceuticals Inc.
$142
Teleflex LLC
$140
Medtronic, Inc.
$133
NeoTract Inc.
$127
Foundation Medicine, Inc.
$123
180 Medical, Inc.
$95
Merck Sharp & Dohme LLC
$94
Antares Pharma, Inc.
$80
AbbVie Inc.
$63
Endo Pharmaceuticals Inc.
$63
UroGen Pharma, Inc.
$63
Sumitomo Pharma America, Inc.
$62
Telix Pharmaceuticals
$53
Aytu BioScience, Inc
$51
UROGEN PHARMA, INC.
$47
Boston Scientific Corporation
$44
Progenics Pharmaceuticals, Inc.
$43
Avadel Specialty Pharmaceuticals, LLC
$43
Coloplast Corp
$41
TOLMAR Pharmaceuticals, Inc.
$40
Corcept Therapeutics
$40
Palette Life Sciences, Inc.
$36
C. R. Bard, Inc. & Subsidiaries
$36
Gilead Sciences, Inc.
$35
Olympus America Inc.
$29
AbbVie, Inc.
$27
Agiliti Surgical, Inc.
$26
COLOPLAST CORP
$25
BOSTON SCIENTIFIC CORPORATION
$25
DENTSPLY IH AB
$23
Allergan Inc.
$23
ACCORD HEALTHCARE, INC.
$18
Ferring Pharmaceuticals Inc.
$18
IMMUNITYBIO, INC.
$17
Novartis Pharmaceuticals Corporation
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
Photocure Inc
$16
Sun Pharmaceutical Industries Inc.
$14
PROGENICS PHARMACEUTICALS, INC.
$14
Kowa Pharmaceuticals America, Inc.
$14
UROVANT SCIENCES INC
$14
DENTSPLY IH Inc.
$12
Blue Earth Diagnostics Limited
$12
Top 3 companies account for 26.6% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · ANKTIVA · AVEED · Androgel · Axumin · BOTOX · BRACAnalysis CDx · Bard Urinary Drainage Bag · CAMCEVI · CONTINENCE CARE · CYSVIEW · ELIGARD · ERLEADA · Erleada · FOUNDATIONONE · GEMTESA · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · Korlym · LEXISCAN · LOFRIC · LUPRON DEPOT · LoFric · MYRBETRIQ · Myrbetriq · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · SPACEOAR VUE · SPEEDICATH · SUTENT · Seglentis · Sonablate HIFU · SpeediCath · TOVIAZ · UROLIFT · UroLift · UroLift System · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
52
County median income
$122,727
Nearest hospital to ZIP centroid (approximate)
OCEAN MEDICAL CENTER
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Perlmutter is a clinical cardiology specialist, with above-average Medicare volume (top 28% in NJ), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Perlmutter experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Perlmutter performed 1,046 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Perlmutter receive payments from pharmaceutical companies?
Yes. Dr. Perlmutter received a total of $4,874 from 53 companies across 284 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perlmutter's costs compare to other urology physicians in Manasquan?
Dr. Perlmutter's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perlmutter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Manasquan
Browse urology physicians in Manasquan ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology